Analysis of Lymphocyte Subpopulations and Cytokines in COVID-19-Associated Pneumonia and Community-Acquired Pneumonia

J Immunol Res. 2021 Jun 9:2021:6657894. doi: 10.1155/2021/6657894. eCollection 2021.

Abstract

Background: The 2019 novel coronavirus SARS-CoV-2 caused large outbreaks of COVID-19 worldwide. COVID-19 resembles community-acquired pneumonia (CAP). Our aim was to identify lymphocyte subpopulations to distinguish between COVID-19 and CAP.

Methods: We compared the peripheral blood lymphocytes and their subsets in 296 patients with COVID-19 and 130 patients with CAP. Parameters for independent prediction of COVID-19 were calculated by logistic regression.

Results: The main lymphocyte subpopulations (CD3+CD4+, CD16+CD56+, and CD4+/CD8+ ratio) and cytokines (TNF-α and IFN-γ) of COVID-19 patients were significantly different from that of CAP patients. CD16+CD56+%, CD4+/CD8+ratio, CD19+, and CD3+CD4+ were identified as predictors of COVID-19 diagnosis by logistic regression. In addition, the CD3+CD4+counts, CD3+CD8+ counts, andTNF-α are independent predictors of disease severity in patients.

Conclusions: Lymphopenia is an important part of SARS-CoV-2 infection, and lymphocyte subsets and cytokines may be useful to predict the severity and clinical outcomes of the disease.

MeSH terms

  • Adult
  • Aged
  • CD4-CD8 Ratio*
  • COVID-19 / blood*
  • COVID-19 / immunology
  • COVID-19 / pathology
  • COVID-19 Testing
  • Community-Acquired Infections / microbiology
  • Female
  • Humans
  • Interferon-gamma / blood*
  • Lymphocyte Subsets / cytology*
  • Lymphocyte Subsets / immunology
  • Lymphopenia / blood
  • Lymphopenia / pathology
  • Male
  • Middle Aged
  • Pneumonia / blood*
  • Pneumonia / immunology
  • Pneumonia / pathology
  • Prognosis
  • SARS-CoV-2 / immunology
  • Severity of Illness Index
  • Tumor Necrosis Factor-alpha / blood*

Substances

  • IFNG protein, human
  • TNF protein, human
  • Tumor Necrosis Factor-alpha
  • Interferon-gamma